Printer Friendly
The Free Library
14,718,018 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Medidata Solutions to Provide in-House Electronic Data Capture Solution for Kendle; Leading Global Clinical Research Organization Leverages Medidata's ASPire to Win(TM) Program to Increase Clinical Trial Efficiencies.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced it has entered into a strategic relationship with Kendle (Nasdaq: KNDL), a leading global full-service clinical research organization (CRO). Through Medidata's ASPire to aspire to
verb aim for, desire, pursue, hope for, long for, crave, seek out, wish for, dream about, yearn for, hunger for, hanker after, be eager for, set your heart on, set your sights on, be ambitious for
 Win Program, Kendle will use Medidata Rave to enhance its electronic data capture (EDC EDC

See: Export Development Corp.
) management and analysis functions for Phase II-IV clinical studies.

Kendle selected Medidata Rave based on its advanced global capabilities and widespread user appeal. Rave will enable Kendle to offer its biopharmaceutical customers an EDC solution that will increase site adoption by providing remote access to data and reports in real-time and offering the ability to clean and lock data more rapidly. In addition, Rave's unique local language and translation features will support Kendle's focus on continued growth and expansion in Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. , Central and Eastern Europe The term "Central and Eastern Europe" came into wide spread use, replacing "Eastern bloc", to describe former Communist countries in Europe, after the collapse of the Iron Curtain in 1989/90. , Asia/Pacific and Africa.

Medidata's ASPire to Win Program is a non-exclusive application service provider (ASP) partnership and business model, enabling Kendle to become Medidata Rave-trained and certified See certification. . This will allow Kendle to offer the Rave platform in-house, draw on Medidata's expertise, and ultimately expedite ex·pe·dite  
tr.v. ex·pe·dit·ed, ex·pe·dit·ing, ex·pe·dites
1. To speed up the progress of; accelerate.

2.
 the delivery of clinical trial data for the company's customers.

"Our strategic relationship with Medidata will provide a stable, robust, intuitive and flexible architecture to help maximize product life cycles," said Gregg Dearhammer, vice president, biometrics, Kendle. "Medidata's proven track record and our shared customer base will ensure a smooth transition to the Rave solution."

"Kendle is a natural partner for us as both companies continue to expand international reach and drive clinical trial efficiencies," said Tarek Sherif she·rif also sha·rif  
n.
1. A descendant of the prophet Muhammad through his daughter Fatima.

2. The chief magistrate of Mecca in Ottoman times.

3. A Moroccan prince or ruler.
, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Medidata Solutions. "We are excited for Kendle to become an ASPire to Win partner, and look forward to enhancing the company's skills and capabilities to cost-effectively implement advanced clinical trial technology."

Kendle has begun customer implementation primarily across Phase II-IV clinical studies and expects implementation of Rave to be completed in May.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. The company delivers innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share. With the expertise of its nearly 2,000 associates worldwide, Kendle has conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries. Kendle was the 10th best-performing stock on the Nasdaq for 2005. Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower Carew Tower is the tallest building in Cincinnati, Ohio, United States. It stands 49 stories tall in the heart of downtown, overlooking the Ohio River waterfront, and is a national historic landmark. , 441 Vine Street
For the street in London, see Vine Street, Westminster.
Vine is a street in Hollywood, Los Angeles, California that runs south — north — north — south from Melrose Avenue up past Hollywood Boulevard.
, Cincinnati, OH 45202, or from our corporate Web site at www.kendle.com.

About Medidata Solutions Worldwide

Medidata Solutions helps the world's leading pharmaceutical, biotechnology, medical device and research organizations maximize the value of their clinical research investments. Innovative process design, technology and services streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Working with companies and institutions both large and small, Medidata Solutions helps accelerate the process of safely bringing life-enhancing treatments to market - on five continents and in more than 70 countries. Medidata Solutions brings significant value to its broad client base with deep clinical experience and expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. For more information, please visit www.mdsol.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 3, 2006
Words:562
Previous Article:SRI International Researchers to Present New Findings at Annual American Education Research Association (AERA) Meeting; Presentations to Focus on...
Next Article:PlanView Appoints Patrick Tickle as Chief Marketing Officer.
Topics:



Related Articles
Phase Forward to Host Fourth Annual International Users Conference.
invivodata Announces the Industry's First Truly Global Electronic Patient Diary Solution; Exclusive Wireless Cradle Simplifies Data Uploads Across...
Baylor College of Medicine to Deploy Institution-wide Electronic Data Capture Software for Clinical Trials.
invivodata Announces Expanded Services From PRO Consulting; Extended Team of Scientific and Regulatory Experts Ensure Data Integrity in Clinical...
invivodata Expands Its Wireless Global Solution Offering; Innovative Tool Gives Trial Sponsors Options for Reliable Data Uploads.(Company overview)
Medidata Solutions and Cytel Inc. First to Integrate Flexible Patient Randomization in EDC Platform for Clinical Trials.
Medidata Solutions to Shape Industry Dialogue at CDISC Interchange and Clinical Research Workshop.
invivodata and Medidata Solutions Announce Integration of DiaryPRO and Medidata Rave; Nabi Biopharmaceuticals Deploys Integrated Solution to Increase...
CardioVascular BioTherapeutics Signs Agreement with Kendle for Phase II Clinical Trial.
invivodata Initiates Set of ePRO Clinical Trials in Japan; Exclusive Relationship With Dendrite Japan Ensures Seamless Trial Execution.(Company...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles